[go: up one dir, main page]

ZA987904B - Use of sulfated oligosaccharides as inhibitors of cardiovascular disease - Google Patents

Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Info

Publication number
ZA987904B
ZA987904B ZA987904A ZA987904A ZA987904B ZA 987904 B ZA987904 B ZA 987904B ZA 987904 A ZA987904 A ZA 987904A ZA 987904 A ZA987904 A ZA 987904A ZA 987904 B ZA987904 B ZA 987904B
Authority
ZA
South Africa
Prior art keywords
inhibitors
cardiovascular disease
sulfated oligosaccharides
sulfated
oligosaccharides
Prior art date
Application number
ZA987904A
Other languages
English (en)
Inventor
William Butler Cowden
Douglas J Francis
Christopher Richard Parish
Original Assignee
Australian Nationa University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Australian Nationa University filed Critical Australian Nationa University
Publication of ZA987904B publication Critical patent/ZA987904B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA987904A 1997-09-01 1998-08-31 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease ZA987904B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO8884A AUPO888497A0 (en) 1997-09-01 1997-09-01 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Publications (1)

Publication Number Publication Date
ZA987904B true ZA987904B (en) 1999-03-01

Family

ID=3803170

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA987904A ZA987904B (en) 1997-09-01 1998-08-31 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease

Country Status (11)

Country Link
US (1) US6638916B1 (xx)
EP (1) EP1024813A4 (xx)
JP (1) JP2001514229A (xx)
CN (1) CN1272060A (xx)
AU (1) AUPO888497A0 (xx)
BR (1) BR9811422A (xx)
CA (1) CA2302154A1 (xx)
IL (1) IL134761A0 (xx)
TW (1) TW438594B (xx)
WO (1) WO1999011273A1 (xx)
ZA (1) ZA987904B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101854L (sv) * 2001-05-28 2002-11-29 Bioneris Ab Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
EP1709443A2 (en) 2003-12-18 2006-10-11 Procognia, Ltd. Method for analyzing a glycomolecule
CN101686918B (zh) * 2007-06-28 2014-05-21 巴斯夫美容护理法国公司 减肥组合物
CA2954662C (en) 2014-07-09 2024-03-19 Midori Usa, Inc. Oligosaccharide compositions and methods for producing thereof
EP4209130A1 (en) 2015-01-26 2023-07-12 DSM Nutritional Products, LLC Oligosaccharide compositions for use animal feed and methods of producing thereof
SI3285777T1 (sl) 2015-04-23 2022-02-28 Kaleido Biosciences, Inc. Glikanski terapevtiki in postopki zdravljenja
WO2017083520A1 (en) * 2015-11-13 2017-05-18 Cadena Bio, Inc. Animal therapeutic and feed compositions and methods of use

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55105700A (en) * 1979-02-09 1980-08-13 Yamasa Shoyu Co Ltd S-adenosyl-l-methionine-containing composition and its preparation
FR2535324A1 (fr) 1982-10-27 1984-05-04 Choay Sa Station perfectionnee pour l'epuration d'eaux usees
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
FR2584606A1 (fr) 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
IT1230582B (it) * 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
US5298616A (en) * 1990-10-03 1994-03-29 Hoffmann-La Roche Inc. Sulfated O-polysaccharide-trehaloses
IT1242604B (it) * 1990-11-13 1994-05-16 Alfa Wassermann Spa Sali di glicosaminoglicani con esteri di aminoacidi, loro preparazione e formulazioni farmaceutiche che li contengono.
CA2061370A1 (en) * 1991-03-13 1992-09-14 Markus Hosang Pharmaceutical preparations
CA2108569A1 (en) 1991-04-17 1992-10-18 H. Edward Conrad Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
IT1251182B (it) 1991-08-28 1995-05-04 Opocrin Spa Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche.
WO1993009790A1 (en) 1991-11-11 1993-05-27 The Trustees Of The University Of Pennsylvania Methods of inhibiting restenosis
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5739115A (en) * 1993-10-07 1998-04-14 Glycomed Incorporated Sulfated maltooligosaccharides with heparin-like properties
JPH09503510A (ja) * 1993-10-07 1997-04-08 グリコメド・インコーポレイテッド ヘパリン様特性を有する高硫酸化マルトオリゴ糖
WO1995033468A1 (en) 1994-06-06 1995-12-14 Oestergaard Per Bjoern A pharmaceutical composition comprising oligosaccharides binding to lipoprotein lipase
US5464827A (en) * 1994-06-20 1995-11-07 American Home Products Corporation Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors
AUPN261895A0 (en) * 1995-04-28 1995-05-18 Australian National University, The Preparation and use of sulfated oligosaccharides
WO1997022628A1 (en) * 1995-12-20 1997-06-26 Taiho Pharmaceutical Co., Ltd. Intravascular membrane thickening inhibitor

Also Published As

Publication number Publication date
IL134761A0 (en) 2001-04-30
EP1024813A1 (en) 2000-08-09
BR9811422A (pt) 2000-08-22
WO1999011273A1 (en) 1999-03-11
CA2302154A1 (en) 1999-03-11
AUPO888497A0 (en) 1997-09-25
JP2001514229A (ja) 2001-09-11
CN1272060A (zh) 2000-11-01
EP1024813A4 (en) 2002-08-28
TW438594B (en) 2001-06-07
US6638916B1 (en) 2003-10-28

Similar Documents

Publication Publication Date Title
EP1131415A4 (en) PRODUCTION OF CHEAP OLIGOSACCHARIDES
IL142490A0 (en) ENZYMATIC SYNTHESIS OF ssDNA
ATE249189T1 (de) Körperreinigungsmittel
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
GB2323530B (en) Amelioration of dupuytrens disease
HUP0101328A3 (en) Soap gel based glue stick
ZA982050B (en) Sulfated oligosaccharides having anticoagulant/antithrom-botic activity
IL134761A0 (en) Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
PL341561A1 (en) Dish-washing agent compact of specific solubility
ID24927A (id) Proses sintesis zat-antara kloropurin
IL135605A0 (en) Use of sulfated oligosaccharides in lowering blood triglyceride levels
IT1290071B1 (it) Sintesi completamente transglicolica di oligosaccaridi ramificati
IL130670A0 (en) Manufacture of elongate members
AP9901651A0 (en) Nitro-benzamide useful as anti-arrhytmic agent
PL325816A1 (en) Novel derivatives of naphtylpiperazine
EP0763342A4 (en) DRAIN VALVE FOR SPHYGMOMANOMETER WITH CONSTANT PRESSURE DROP
ZA963356B (en) Novel uses of heptafluoropropane
GB9713139D0 (en) Use of enzymes
TW319017U (en) Improved structure of mousetraps
TW320013U (en) Improved structure of shoes cabinet
TW411783U (en) Improved structure of shoes
TW339575U (en) Improved structure of shoes
TW309934U (en) Structure of cigarrette shelf
AU6854398A (en) Hyaluronate synthesis inhibitors
TW310559U (en) Improved structure of drawer